+ All Categories
Home > Documents > Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Date post: 18-Apr-2015
Category:
Upload: mohammed-sarhan
View: 16 times
Download: 1 times
Share this document with a friend
50
New member Egyptian society of Parasitologists United: new associated member of the EFP Hundreds of members affiliated through > 30 national societies
Transcript
Page 1: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

New member

Egyptian society of Parasitologists United: new associated member of

the EFP

Hundreds of members affiliated through > 30 national societies

Page 2: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

• EFP promotes exchange of knowledge & research

• EFP holds EMOP conferences every 4 years– Awards Young

Scientists in "Basic Parasitology" & “Applied Parasitology“

– Scholarships to cover registration fees for young parasitologists

http://europfedpar.monsite-orange.fr/

European Federation of Parasitologists

Page 3: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Newsletter

Page 4: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

EMOP XII Turku/Åbo, Finland, 20-24 July, 2016

“Parasites are forever”

Page 5: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Prevention of congenital

toxoplasmosis

Jean Dupouy-CametAccredited laboratory for diagnosis of

congenital toxoplasmosis, Cochin Hospital, Paris Descartes University

France

Page 6: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Pappas , 2009

> 60 %

40-60 %

20-40 %

10-20 %

< 10 %

Worldwide zoonosis with variable seroprevalence

Page 7: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

• Most of the time asymptomatic– in mothers– in 75 % of fœtus & newborns (prenatal treatment ?)

• Sometimes symptomatic– in mothers : flu or dengue-like syndrome, lymph

nodes enlargement, blood monocytosis

– severe in fœtus & newborns: retinitis, hepatosplenomegaly, brain calcifications, hydrocephalus, foetal death…

Clinical patterns of infections during

pregnancy

Page 8: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

T. Ancelle, Parasitologie, Cochin Paris Descartes

Risk of infection increases with the pregnancy age but incidence of severe

forms decreases

0

10

20

30

40

50

60

70

80

90

100

0 13 26 39

semaines de gestation

D’après D.Dunn et coll . Lancet 1999;353:1829-33

Average risk :

Fetal infection : (29 %)

%

clinical signs

Weeks of pregnancy

Page 9: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

brain calcifications

hydrocephalus & calcifications at fetal echography :

Page 10: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

- Can be diagnosed years after birth

- Clinical signs & prognosis depend on inflammatory reaction and localization (blindness if macular)

Chorioretinitis

Active lesion Scar

Page 11: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Contact with cats is not a risk factor !

Significant factors :•Raw undercooked lamb OR 3.1•Raw undercooked beef OR 1.7•Raw other meat OR 4.1•Contact with soil OR 1.8 •Travel outside Europe/US OR 2.3

Sources of infection during pregnancy in Europe

(Cook et al, 2000)

Page 12: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Social pressure to eat raw food in

Europe !Carpaccio…

Raw foodism & new diets : instinctive eating, Paleolithic diet..

Page 13: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Meat consumption is not a risk factor in Egypt

Page 14: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Goats, sheeps & toxoplasmosis

•Seroprevalence ranging from 33 to 50 % of goats & 95 to 100 % of sheeps in El Fayoum (Ghoneim et al. 2010) & positive PCR from blood•Very few reports milk or cheese as source of human toxoplasmosis

Chiari CA, Neves DP 1984. Toxoplasmose humana adquirida através da ingestão de leite de cabra. Mem Inst Oswaldo Cruz 79: 337-340.

Page 15: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Very few studies on the survival of tachyzoïtes in

goat milk !

• Samples of goat milk spiked with small numbers of tachyzoïtes were positive for 3 days at 4° C, while samples of goat milk spiked with large numbers of tachyzoïtes were positive for 7 days at 4° C. (Journal of Eukaryotic Microbiology, 1999)

Page 16: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Prevention for toxoplasmosis

1.Primary prevention : hygienic rules

2.Secondary prevention : antibody screening, spiramycin, antenatal & neonatal diagnosis

3.Tertiary prevention : antenatal and post natal treatment

Page 17: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Teaching hygienic rules is not easy !

• Information given by books or magazine 16 fold risk reduction

• Information given by physicians 6 fold risk reduction (NS)

• Written information 14 fold risk reduction

• Oral information 6 fold risk reduction (NS)

BEH n°16 (16 avril 1996

Page 18: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

French official hygienic rules

Complicated

Difficult to read

Illustrate only gardening !

Page 19: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Primary prevention in the NY Times

Page 20: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Primary prevention in the NY Times

Some rules are lacking : raw vegetables, gardening !!

Contaminated meat not very clear: contaminated by cats ?

raw meat is not mentioned..

Page 21: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

The French programme

• Implemented 30 years ago by Desmonts, Chevallier, Garin, Couvreur

• Observation of “numerous” congenital cases (no precise baseline data)

• Based at first on serologic surveillance & spiramycin

Page 22: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Prevention program in the law

1978: mandatory Toxoplasma serology for the medical certificate before wedding

1983: hygienic rules given to unprotected women during pregnancy

1985: mandatory Toxoplasma serology at the first prenatal medical exam

1992: mandatory monthly Toxoplasma serology for non protected pregnant women

2006: National reference Center (Reims, Pr I Villena)

Page 23: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Seroconversion during pregnancy

•Treatment by spiramycin (prevents transplacental passage ?)

9M IU tid

•Prenatal diagnosis – At least 4 weeks after infection– At least after 16 weeks of pregnancy

Page 24: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Prenatal diagnosis on amniotic fluid

Positive Negative

If severe lesions

At birth : clinical examination, serology, echography

Pregnancy interruptio

n

Echography every month spiramycin

sulfadiazin-pyrimetami

ne or

sulfadoxin-pyrimetami

ne

Page 25: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Prenatal diagnosis by PCR on amniotic fluid

19921990

First results published by our lab in 1990 & 1992 targeting P30 gene

Our results in 1999

Page 26: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

• Clinical examination of the newborn• Fundus examination

• Transfontanellar echography

• Serology– Evolution of antibodies for 12 months– OR Comparative WB

Neonatal diagnosis

Page 27: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Neonatal diagnosis : Comparative WB M N M N M N M N

positive neonatal diagnosis negative neonatal diagnosis

Page 28: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Infected new born

• Treatment : sulfadoxine pyrimethamine or sulfadiazine pyremethamine during at least 12 months + folinic acid

• Blood cells counts every month

• Eye examination every 3 months

Page 29: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Evaluation of the French program

• No snap shot of the epidemiological situation at onset of the program 30 years ago…

• Difficult(impossible ?) to evaluate the impact of the program

Page 30: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Of which :- 72 fœtal deaths,

stillbirth & abortions- 29 severe cases

(hydrocephalus, retinitis…)

-Around 300 cases for 800 000 births/year

Still more than 1000 cases of congenital toxoplasmosis in France (2007-2010)Report of the NRC

Page 31: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

A discussed effectiveness of the prenatal treatment

SYROCOT Thiebaut R, Leproust S, Chene G, Gilbert R. Lancet. 2007 Jan 13;369(9556):115-22.

Page 32: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Analysis of 26 cohorts

• « 1438 treated mothers : weak evidence that spiramycin started within 3 weeks of seroconversion reduced mother-to-child transmission compared with treatment started after 8 or more weeks »

• « 550 infected live born infants:no evidence that prenatal treatment significantly reduced the risk of clinical manifestations »

Page 33: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

No major incidence of the type of screening on the delay of detection of ocular toxoplasmosis Freeman, K. et al. 2008

Monthly screening : France

Every 3 months : Italy, Austria

Neonatal : Poland, Scandinavia

Page 34: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

However, for some authors, congenital toxoplasmosis should be diagnosed and treated early during pregnancy

Page 35: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Prenatal treatment decreases severe sequelae incidence from 20 to 3.5 %

Page 36: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Conclusions

• Is there still a need for screening congenital toxoplasmosis ?

Page 37: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Disease Incidence / 1000 births

Congenital Toxoplasmosis 0.4 Moderate & severe forms 0.05 Severe forms 0.02

Rubella 0

Congenital syphilis 0.008

Phenylketonuria* 0.06

Surrenal hyperplasia* 0.06

Cystic fibrosis* 0.25

Hypothyroidism* 0.3

*From Ardaillou & Le Gall, 2007, Perel et al, 2011, Villena et al, 2010

Incidence of some screened congenital diseases (France)

Page 38: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

A 48% seroprevalence in pregnant women (Alexandria)

Page 39: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Estimated number of cases of congenital toxoplasmosis in

Egyptpregnancies / year 2 millions

population at risk : 52 % 1. 04 millions

Ab prevalence : 48 %

contamination : 0.3 % 3100

estimated fetal transmission : 30 %

> 1000 estimated cases/year

Page 40: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Conclusions

• Is there still a need for screening congenital toxoplasmosis ? YES

• There is a cost : a choice of society

Page 41: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Annual cost of the French program : 100 millions $

Prevention of costs

Page 42: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Costs of congenital defects

• Costs in US of congenital defects (Stillwaggon et al., 2011):– Fetal death 7 M $– Mild visual defect 0.5 M $– Severe visual defect 1 M $– Mild cognitive defect 1 M $– Severe cognitive defect 2.7 M $

• Costs for the «whole life» of a severely disabled person > 4 M $

Page 43: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Costs could be reduced by a minimum program

• A. Hygienic rules if seronegativity when pregnancy is identified

• B. Repeated echographies at regular intervals (termination if severe lesions) ethics, religion…

• C. Neonatal screening & treatment of infected newborns (1 year)

Options ? : A or B or C, A+ B, A + C, A+ B + C…

Page 44: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

From the ethical and medical point of view : prevention

seems compulsory

Page 45: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

But…economical pressure…crisis !

Page 46: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final
Page 47: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final
Page 48: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

A 48% seroprevalence in pregnant women (Menoufia)

Page 49: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Seroprevalence ranging from 42 to 48 % in pregnant women (El Fayoum)

Page 50: Short Dupouy-camet Prevention of Toxoplasmosis Le Caire Final

Recommended